ConductScience.org, home

Paper12373594

Platinum drugs in the treatment of non-small-cell lung cancer.

Cosaert J and 1 other. Br J Cancer, 2002. Cited by 78 papers, by iCite.

Cite this record

ConductScience Library. Platinum drugs in the treatment of non-small-cell lung cancer. Papers, record 12373594. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12373594

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Platinum drugs in the treatment of non-small-cell lung cancer.
PubMed
Journal
Br J Cancer
PubMed
Year
2002
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
78
iCite
Relative citation ratio, by iCite
1.56
iCite
Revised in PubMed
2024-09-30
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cosaert JJ
2Quoix EE

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic Combined Chemotherapy ProtocolsMajor topic
Carcinoma, Non-Small-Cell LungMajor topic
Lung NeoplasmsMajor topic
Carboplatin
Cisplatin
Clinical Trials as Topic
Combined Modality Therapy
Etoposide
Humans
Paclitaxel

Source PubMed

Download CSV of topics

References94

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110561376Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology.J Clin Oncol1999https://conductscience.org/library/papers/10561376PubMed
27844593Maximum-tolerated doses of ifosfamide, carboplatin, and etoposide given over 6 days followed by autologous stem-cell rescue: toxicity profile.J Clin Oncol1995https://conductscience.org/library/papers/7844593PubMed
310864225Preclinical perspectives on platinum resistance.Drugs2000https://conductscience.org/library/papers/10864225PubMed
42171622Long-term sequelae of treatment for testicular germ cell tumours.Br J Cancer1990https://conductscience.org/library/papers/2171622PubMed
510448284Guidelines for anti-emetic therapy: acute emesis.Eur J Cancer1999https://conductscience.org/library/papers/10448284PubMed
62169587A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer.N Engl J Med1990https://conductscience.org/library/papers/2169587PubMed
71324895Radiotherapy versus radiotherapy enhanced by cisplatin in stage III non-small cell lung cancer.Int J Radiat Oncol Biol Phys1992https://conductscience.org/library/papers/1324895PubMed
82157554A randomized trial fo three cisplatin-containing regimens in advanced non-small-cell lung cancer (NSCLC): a study of the Umbrian Lung Cancer Group.Cancer Chemother Pharmacol1990https://conductscience.org/library/papers/2157554PubMed
99667264Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study.J Clin Oncol1998https://conductscience.org/library/papers/9667264PubMed
1010585004Docetaxel in the treatment of non-small cell lung cancer: review of single-agent trials.Semin Oncol1999https://conductscience.org/library/papers/10585004PubMed
1111843242Do all patients with advanced non-small-cell lung cancer benefit from cisplatin-based combination therapy?Ann Oncol2001https://conductscience.org/library/papers/11843242PubMed
1210550150Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project.J Clin Oncol1999https://conductscience.org/library/papers/10550150PubMed
136540685Vindesine and cisplatin combination chemotherapy compared with vindesine as a single agent in the management of non-small cell lung cancer: a randomized study.Eur J Cancer Clin Oncol1984https://conductscience.org/library/papers/6540685PubMed
143880810Chemotherapy for metastatic non-small-cell bronchogenic carcinoma: EST 2575, generation V--a randomized comparison of four cisplatin-containing regimens.J Clin Oncol1985https://conductscience.org/library/papers/3880810PubMed
1511279780Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable).Cochrane Database Syst Rev2001https://conductscience.org/library/papers/11279780PubMed
162547028Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small-cell lung cancer. Lung Cancer Working Party, Belgium.J Clin Oncol1989https://conductscience.org/library/papers/2547028PubMed
179428487Single agent versus combination chemotherapy in patients with advanced nonsmall cell lung carcinoma: a meta-analysis of response, toxicity, and survival.Cancer1998https://conductscience.org/library/papers/9428487PubMed
188573296Comparative adverse effect profiles of platinum drugs.Drug Saf1995https://conductscience.org/library/papers/8573296PubMed
198718420Current chemotherapy of advanced non-small cell lung cancer.Anticancer Drugs1995https://conductscience.org/library/papers/8718420PubMed
209541678Carboplatin versus cisplatin in solid tumors: an analysis of the literature.Ann Oncol1998https://conductscience.org/library/papers/9541678PubMed

See all 94 referencesDownload CSV of references

Cited by35

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 78 citations.

PMIDTitleJournalYearIn PapersSource
42272260A fibroblast activation protein degrader enhances cisplatin sensitivity in non‑small cell lung cancer.Oncol Rep2026https://conductscience.org/library/papers/42272260PubMed
36498837Recent Advances in Light-Controlled Activation of Pt(IV) Prodrugs.Int J Mol Sci2022https://conductscience.org/library/papers/36498837PubMed
36358986Curcumin and Its Analogs in Non-Small Cell Lung Cancer Treatment: Challenges and Expectations.Biomolecules2022https://conductscience.org/library/papers/36358986PubMed
36358724The Prognostic and Therapeutic Potential of DNA Damage Repair Pathway Alterations and Homologous Recombination Deficiency in Lung Cancer.Cancers (Basel)2022https://conductscience.org/library/papers/36358724PubMed
35875329The emergence of nanoporous materials in lung cancer therapy.Sci Technol Adv Mater2022https://conductscience.org/library/papers/35875329PubMed
35057025pH-Responsive Liposomes of Dioleoyl Phosphatidylethanolamine and Cholesteryl Hemisuccinate for the Enhanced Anticancer Efficacy of Cisplatin.Pharmaceutics2022https://conductscience.org/library/papers/35057025PubMed
34856706A Phase I/IIa Randomized Trial Evaluating the Safety and Efficacy of SNK01 Plus Pembrolizumab in Patients with Stage IV Non-Small Cell Lung Cancer.Cancer Res Treat2022https://conductscience.org/library/papers/34856706PubMed
34502361Battling Chemoresistance in Cancer: Root Causes and Strategies to Uproot Them.Int J Mol Sci2021https://conductscience.org/library/papers/34502361PubMed
34400945Effect of Menadione and Combination of Gemcitabine and Cisplatin on Cancer Stem Cells in Human Non-small Cell Lung Cancer (NSCLC) Cell Line A549.Iran J Pharm Res2021https://conductscience.org/library/papers/34400945PubMed
33884290Organ-restricted vascular delivery of nanoparticles for lung cancer therapy.Adv Ther (Weinh)2020https://conductscience.org/library/papers/33884290PubMed
33805467Targeting AKT/mTOR and Bcl-2 for Autophagic and Apoptosis Cell Death in Lung Cancer: Novel Activity of a Polyphenol Compound.Antioxidants (Basel)2021https://conductscience.org/library/papers/33805467PubMed
32843536Mammalian copper homeostasis requires retromer-dependent recycling of the high-affinity copper transporter 1.J Cell Sci2020https://conductscience.org/library/papers/32843536PubMed
31385067New dinuclear palladium(II) complexes with benzodiazines as bridging ligands: interactions with CT-DNA and BSA, and cytotoxic activity.J Biol Inorg Chem2019https://conductscience.org/library/papers/31385067PubMed
30695050Screening-based approach to discover effective platinum-based chemotherapies for cancers with poor prognosis.PLoS One2019https://conductscience.org/library/papers/30695050PubMed
29536182Paclitaxel and Erlotinib-co-loaded Solid Lipid Core Nanocapsules: Assessment of Physicochemical Characteristics and Cytotoxicity in Non-small Cell Lung Cancer.Pharm Res2018https://conductscience.org/library/papers/29536182PubMed
29247315Development of a copper-clioquinol formulation suitable for intravenous use.Drug Deliv Transl Res2018https://conductscience.org/library/papers/29247315PubMed
29088858Metformin partially reverses the carboplatin-resistance in NSCLC by inhibiting glucose metabolism.Oncotarget2017https://conductscience.org/library/papers/29088858PubMed
27342417ImmunoPET for assessing the differential uptake of a CD146-specific monoclonal antibody in lung cancer.Eur J Nucl Med Mol Imaging2016https://conductscience.org/library/papers/27342417PubMed
26216446Restoration of CBX7 expression increases the susceptibility of human lung carcinoma cells to irinotecan treatment.Naunyn Schmiedebergs Arch Pharmacol2015https://conductscience.org/library/papers/26216446PubMed
25897409Comparison of platinum combination re-challenge therapy and docetaxel monotherapy in non-small cell lung cancer patients previously treated with platinum-based chemoradiotherapy.Springerplus2015https://conductscience.org/library/papers/25897409PubMed

See all 35 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
EPO2056PubTator's text mininghttps://conductscience.org/library/genes/2056NCBI Gene
ERCC12067PubTator's text mininghttps://conductscience.org/library/genes/2067NCBI Gene
TP537157PubTator's text mininghttps://conductscience.org/library/genes/7157NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/12373594

GET https://conductscience.org/api/papers/v1/12373594/references?page=2